While VCAM1 was not downregulated by treatment with the CM from GW3965‐treated EOCs in culture, administration of the CM to atherosclerosis‐prone mice did show a downregulation of endothelial VCAM1 in the aortic sinus, which was associated with a decrease in plaque area. This evidence concerns the gene VCAM1 and atherosclerosis.